Charles River Laboratories International, Inc. Common Stock (NY:CRL)

378.89 +4.91 (+1.31%)

Delayed Quote Updated: 12:45 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

10 Biggest Price Target Changes For Monday ↗

April 25, 2022

Keybanc cut Salesforce, Inc. (NYSE: CRM) price target from $281 to $223. Salesforce shares fell 1.1% to $169.60 in pre-market trading.

Via Benzinga

Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call

April 13, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Publishes 2021 Corporate Citizenship Report

April 07, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Recap: Charles River Q4 Earnings ↗

February 16, 2022

Charles River (NYSE:CRL) reported its Q4 earnings results on Wednesday, February 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 16, 2022 ↗

February 16, 2022

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022 ↗

April 07, 2022

Upgrades

Via Benzinga

Charles River Buys Contract Vivarium Research Services Firm In $295M Deal ↗

April 06, 2022

Charles River Laboratories International Inc (NYSE: CRL) has acquired Explora BioLabs Holdings Inc, a provider of contract vivarium research services,

Via Benzinga

Charles River Laboratories Acquires Explora BioLabs

April 06, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer

March 28, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Markets Fall Amid Rising Oil Prices ↗

March 23, 2022

U.S. indices finished lower Wednesday as investors continue to weigh the Federal Reserve tapering outlook, inflation concerns and the Russia-Ukraine war. Oil prices have also...

Via Benzinga

Inflation Beneficiary ETFs in Focus as Prices Soar ↗

March 15, 2022

Many experts predicted that inflation would cool off in spring as supply chains improve after pandemic-driven disruptions. It now appears that higher inflation could persist for longer.

Via Talk Markets

3 Moonshot Stocks Insiders Are Buying. What Do They Know? ↗

February 25, 2022

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.

Via InvestorPlace

Charles River Earnings Perspective: Return On Invested Capital ↗

February 17, 2022

According to Benzinga Pro, during Q4, Charles River (NYSE:CRL) earned $139.83 million, a 32.97% increase from the preceding quarter. Charles River also posted a total of $905.05 million in sales, a...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

February 17, 2022

Cowen & Co. raised Yum! Brands, Inc. (NYSE: YUM) price target from $134 to $143. Yum! Brands shares fell 0.3% to $123.00 in pre-market trading. Keybanc cut the price target...

Via Benzinga

Charles River's Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook ↗

February 16, 2022

Charles River Laboratories International Inc's (NYSE: CRL)

Via Benzinga

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results

February 16, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Announces Wind Contract with Repsol for European Operations

February 03, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Expands Strategic Partnership With SAMDI Tech

January 27, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call

January 20, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions

January 19, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

The Best and Worst of Q4 Earnings ↗

January 12, 2022

Earnings season begins this week as corporations report their Q4 results and wrap up fiscal year 2021.

Via Talk Markets

Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan

January 11, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Will Chart Analysts Notice Bad Omen on Charles River's Chart ↗

January 07, 2022

If history is any guide, there may be trouble ahead for shares of Charles River (NYSE:CRL). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

January 06, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm ↗

December 08, 2021

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) reported results following toxicology and pharmacokinetic study of Epoladerm to manage pain associated with...

Via Benzinga

Charles River Laboratories to Participate in Upcoming Investor Conferences

November 16, 2021

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer

November 11, 2021

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories International, inc (CRL) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

CRL earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Charles River Laboratories International Shares Dropped 16.7% This Week ↗

November 04, 2021

The company's stock dropped nearly $75 a share over the course of the week, rattling investors.

Via The Motley Fool

Charles River Posts Mixed Q3 Earnings; Narrows FY21 EPS Guidance ↗

November 03, 2021

Charles River Laboratories International Inc (NYSE: CRL) Q3 sales increased 20.5% Y/Y to $895.9 million, missing the consensus of $903.20 million. Acquisitions...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.